Nutrition Research
Volume 25, Issue 1 , Pages 93-102 , January 2005

Garlic extract attenuates hyperhomocysteinemia caused by folic acid deficiency in the rat

  • Yu-Yan Yeh

      Affiliations

    • Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA 16802, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 814 863 2920; fax: +1 814 863 6103.
    • ,
  • Hyeon-Sook Lim

      Affiliations

    • Department of Food and Nutrition, Chonnam National University, Gwangiu 500-757, Republic of Korea
    • ,
  • Shaw-mei Yeh

      Affiliations

    • Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA 16802, USA
    • ,
  • Mary Frances Picciano

      Affiliations

    • Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA 16802, USA
    • Present address: Office of Dietary Supplements, National Institutes of Health, Department of Health and Human Services, 6100 Executive Blvd, Rm 3B01, Bethesda, MD 20892-7517.

Received 20 October 2003 ,Revised 11 October 2004 ,Accepted 29 October 2004.

References 

  1. Stampfer MI, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk?. N. Engl. J. Med. 1995;332:328–329
  2. Malinow MR. Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases. J. Nutr. 1996;126:1238S–1243S
  3. Soysal D, Savas S, Susam I, Cevik C, Goldeli E, Sozmen E, et al. Plasma thiols and androgen levels in polycystic ovary syndrome. Clin. Chem. Lab. Med. 2003;41:216–221
  4. Retterstol L, Paus B, Bohn M, Bakken A, Erikssen J, Malinow MR. Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study. J. Intern. Med. 2003;253:284–292
  5. Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In:  Francis RB editors. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker; 1992;p. 183–236
  6. Stampfer MI, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullman O, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. physicians. JAMA. 1992;268:877–881
  7. Selhub J, Jacques PF, Bostom AG, O'Agostino RB, Wilson PWF, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med. 1995;332:286–291
  8. Brattstrom L, Lindgen A, Isrealsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J. Intern. Med. 1994;236:633–641
  9. Brattstrom L. Vitamins as homocysteine-lowering agents. J. Nutr. 1996;126:1276S–1280S
  10. Selhub J, Jacques PF, Bostom AG, Oagostino RB, Wilson PWF, Belanger AJ, et al. Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham study population. J. Nutr. 1996;126:1258S–1265S
  11. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin. Chem. 1993;39:1764–1779
  12. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch. Intern. Med. 2001;161:695–700
  13. Haynes WG. Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins. Cardiovasc. Drugs Ther. 2002;16:391–399
  14. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J. Nutr. 1994;124:1934–1941
  15. Mansoor MA, Ueland PM, Svardal AM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with hyperhomocysteinemia due to cobalamin deficiency. Am. J. Clin. Nutr. 1994;59:631–635
  16. Clifford AJ, Bills ND, Peerson JM, Muller HG, Burk GE, Rich KD. A depletion-repletion folate bioassay based on growth and tissue folate concentrations of rats. J. Nutr. 1993;123:926–932
  17. Anderssonm A, Isaksson A, Hultberg B. Homocysteine export from erythrocytes and its implication for plasma sampling. Clin. Chem. 1992;38:1311–1315
  18. Miller JW, Nadeau MR, Smith I, Smith O, Selhub J. Folate-deficiency–induced homocysteinemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Biochem. J. 1994;298:415–419
  19. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detector. J. Chromatogr. 1987;422:43–52
  20. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur. J. Clin. Chem. 1991;29:549–554
  21. Tamura T. Microbiological assay of folate. In:  Picciano MF,  Stokstad ELR,  Grepory JF editor. Folic acid metabolism in health and disease. New York (NY): Wiley-Liss; 1990;p. 121–137
  22. Wilson SD, Horne DW. Use of glycerol-cryoprotected Lactobacillus casei for microbiological assay of folic acid. Clin. Chem. 1982;28:1198–1200
  23. Wilson SD, Horne DW. High-performance liquid chromatographic determination of the distribution of naturally occurring folic acid derivatives in rat liver. Anal. Biochem. 1984;142:529–535
  24. Tamura T, Mison Y, Johnston KE, Jacob RA. Food folate assay with protease, α-amylase, and folate conjugase treatment. J. Agric. Food Chem. 1997;45:133–139
  25. Clarke R, Daly L, Robinson K, Naughten E, Cahalane E, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 1991;324:1149–1155
  26. Takenaka T, Shimomura T, Nakayasu H, Urakami K, Takahashi K. Effect of folic acid for treatment of homocystinuria due to 5, 10-methylenetetrahydrofolate reductase deficiency. Rinsho Shinkeigaku. 1993;33:1140–1145
  27. Mager A, Battler A, Birnbaum Y, Magal N, Shohat M. Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia. Am. J. Cardiol. 2002;89:919–923
  28. Kumar KS, Govindaiah V, Naushad S, Devi RR, Jyothy A. Plasma homocysteine levels correlated to interaction between folate status and methylene tetra-hydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. J. Obstet. Gynaecol. 2003;23:55–58
  29. Venn BJ, Green TJ, Moser R, Mann JI. Comparison of the effect of low-dose supplementation with l-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. Am. J. Clin. Nutr. 2003;77:658–662
  30. SoRelle R. Folate reduces homocysteine levels and lowers rate of restenosis. Circulation. 2001;104:E9050–E9060
  31. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N. Engl. J. Med. 2001;345:1593–1600
  32. Ozkan Y, Ozkan E, Simsek B. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int. J. Cardiol. 2002;82:269–277
  33. Mansoor MA, Svardal AM, Schneede J, Ueland PM. Dynamic relation between reduced, oxidized, and protein-bound homocysteine and other thiol compounds in plasma during methionine loading in health men. Clin. Chem. 1992;38:1613–1621
  34. Liu L, Yeh YY. Inhibition of cholesterol biosynthesis by organosulfur compounds derived from garlic. Lipids. 2000;35:197–203
  35. Lawson LD. Bioactive organosulfur compounds of garlic and garlic products. In:  Kinghorn AD,  Balandrin MF editor. Human medical agents from plants. Washington (DC): American Chemical Society; 1993;p. 307–330
  36. Selhub J. Homocysteine metabolism. Annu. Rev. Nutr. 1999;19:217–246
  37. Green R, Jacobsen DW. Clinical implications of hyperhomocysteinemia. In:  Baily LB editors. Folate in health and disease. New York (NY): Marcel Dekker Inc; 1995;p. 75–123
  38. Oltean S, Banerjee R. Nutritional modulation of gene expression and homocysteine utilization by vitamin B12. J. Biol. Chem. 2003;278:20778–20784
  39. Mason JB. Biomarker of nutrient exposure and status in one-carbon(methyl) metabolism. J. Nutr. 2003;133:941S–945S
  40. Oliveriusova J, Kery V, Maclean KN, Kraus JP. Deletion mutagenesis of human cystathionine beta-synthase. Impact on activity, oligomeric status, and S-adenosylmethionine regulation. J. Biol. Chem. 2002;277:48386–48394
  41. Gaytan RJ, Prisant LM. Oral nutritional supplements and heart disease: a review. Am. J. Ther. 2001;8:255–274

PII: S0271-5317(04)00198-8

doi: 10.1016/j.nutres.2004.10.004

Nutrition Research
Volume 25, Issue 1 , Pages 93-102 , January 2005

Article Tools

* Image Usage & Resolution